Skip to main content
. 2017 Oct 22;82(4):615–621. doi: 10.1002/ana.25059

Figure 3.

Figure 3

Improvement of cerebellar hypometabolism after 40‐week docosahexaenoic acid (DHA) treatment in spinocerebellar ataxia 38 (SCA38) patients. Pattern of cerebellar metabolism in SCA38 patients at baseline versus 40‐week DHA treatment (baseline < 40‐week DHA treatment, p < 0.05, false discovery rate corrected). See Results for details. The results are superimposed on a 3‐dimensional standardized template and axial magnetic resonance imaging template. L = left; R = right; Z = Montreal coordinates.